CLiTICAL
Everyone
info
0+
Downloads
Everyone
Learn more
About this app
The app has been completely revamped with a new version.
This app is designed to perform risk assessments based on the findings presented in the papers (Miyata T et al, Br J Surg. 2022 and Miyata T et al, Euro J Endovasc Surg. 2022) by the Japanese Society for Vascular Surgery (JCLIMB) Committee, which investigated the prognosis of patients with comprehensive severe chronic lower limb ischemia (CLTI) after revascularization. This app does not constitute medical treatment or health guidance, and does not guarantee any effect on the treatment or improvement of symptoms of specific diseases or other health conditions. Furthermore, we assume no responsibility whatsoever for any results resulting from the use of this app.
This app is designed to perform risk assessments based on the findings presented in the papers (Miyata T et al, Br J Surg. 2022 and Miyata T et al, Euro J Endovasc Surg. 2022) by the Japanese Society for Vascular Surgery (JCLIMB) Committee, which investigated the prognosis of patients with comprehensive severe chronic lower limb ischemia (CLTI) after revascularization. This app does not constitute medical treatment or health guidance, and does not guarantee any effect on the treatment or improvement of symptoms of specific diseases or other health conditions. Furthermore, we assume no responsibility whatsoever for any results resulting from the use of this app.
This is an app for predicting the prognosis after revascularization in CLTI patients.
Updated on
Safety starts with understanding how developers collect and share your data. Data privacy and security practices may vary based on your use, region, and age. The developer provided this information and may update it over time.
- No data shared with third partiesLearn more about how developers declare sharing
- No data collectedLearn more about how developers declare collection
What’s new
アイコンの変更と、初回起動場面の改善を行いました。
